
Rivamus 2.5mg Tablet
Marketer
Optimus Pharma Pvt Ltd
Salt Composition
Rivaroxaban (2.5mg)
Overview Rivamus 2.5mg Tablet
ThromboGuard 2.5mg tablets function as an anticoagulant, preventing and treating blood clots. This medication lowers the risk of stroke and heart attack by inhibiting clot formation in leg, lung, brain, and heart veins. Frequently prescribed for patients with atrial fibrillation to prevent clots, it also mitigates clotting risks post-knee or hip replacement. It can be administered with or without food, consistently at the same time daily for optimal efficacy. Long-term use, potentially lifelong, may be necessary; discontinuation or dosage alteration requires physician consultation to avoid increased stroke, heart attack, or thrombosis risk. Lifestyle modifications—such as avoiding smoking, adopting a healthy diet, exercising regularly, and achieving a healthy weight—further reduce clot risk. Increased bleeding susceptibility (e.g., nosebleeds, bruising) is a common side effect; report any unusual symptoms promptly. Contraindicated in patients with severe liver or kidney disease, active bleeding, or concurrent use of other anticoagulants. Breastfeeding is not recommended during treatment. Unlike some anticoagulants, routine PT-INR monitoring isn't needed.
Primary Ingredients of Rivamus 2.5mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Rivamus 2.5mg Tablet
Managing and averting blood clot formation
Major Benefits of Rivamus 2.5mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Rivamus 2.5mg tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Rivamus 2.5mg Tablet:
- Bleeding
How to use Rivamus 2.5mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Rivamus 2.5mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Rivamus 2.5mg Tablet works:
Xaltia 2.5mg tablets represent a new class of oral blood thinners. Their mechanism of action involves inhibiting factor Xa, a key clotting agent, thereby reducing the risk of dangerous blood clot development.
SAFETY ADVICE
AlcoholCAUTION
Use of Rivamus 2.5mg Tablet with alcohol requires careful consideration. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Rivamus 2.5mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against possible risks prior to prescribing. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Based on limited available data from humans, the administration of Rivamus 2.5mg tablets while breastfeeding is likely inadvisable due to the potential for the medication to transfer into breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving may be impaired by Rivamus 2.5mg Tablet, which can induce dizziness or loss of consciousness. The potential for side effects affecting driving ability exists with Rivamus 2.5mg Tablet use.
KidneyCAUTION
Patients with kidney impairment should use Rivamus 2.5mg tablets cautiously, potentially requiring dosage modification under medical supervision. Rivamus 2.5mg tablets are contraindicated in patients with severe kidney disease.
LiverUNSAFE
Patients with liver disorders should likely refrain from using Rivamus 2.5mg tablets due to potential safety concerns. Medical advice is recommended.
What if you forget to take Rivamus 2.5mg Tablet :
Should you forget a Rivamus 2.5mg Tablet dose, take it immediately if you remember. However, if your next dose is imminent, omit the missed one and resume your usual dosing pattern. Never take a double dose.
Facts to Know About Rivamus 2.5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Morpholine and thiophene derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | Xa Inhibitors (Oral) |
